Featured Research

from universities, journals, and other organizations

Leptin May Hold Key To Better Weight Loss

Date:
October 1, 2001
Source:
Columbia University College Of Physicians And Surgeons
Summary:
New York, NY- Dieters know the phenomenon all too well: They cut calories, exercise, and lose some weight but at some point they can't seem to get rid of any more of the excess poundage. Now researchers from Columbia University College of Physicians & Surgeons, St. Luke's-Roosevelt Hospital Center, and the Weill Medical College of Cornell University, in a study of rats, may have some new clues why the plateau effect occurs and what could be done to overcome it.

New York, NY- Dieters know the phenomenon all too well: They cut calories, exercise, and lose some weight but at some point they can't seem to get rid of any more of the excess poundage.

Now researchers from Columbia University College of Physicians & Surgeons, St. Luke's-Roosevelt Hospital Center, and the Weill Medical College of Cornell University, in a study of rats, may have some new clues why the plateau effect occurs and what could be done to overcome it. The findings have led to clinical tests in people.

The investigators theorized that rats--and humans--may not be able to lose weight after a certain amount of dieting, even with drugs or surgery, such as gastric bypass, because the loss of fat decreases the amount of the hormone leptin in the body.

Leptin, a hormone mostly manufactured by fat cells, is present in obese animals (and humans) but as the animal loses fat, levels of the hormone go down. With reduced levels of the leptin, the researchers say, the brain mistakenly thinks the animal needs food and sends signals to the body to slow metabolism down and increase appetite, two conditions that make it harder to fight the battle of the bulge.

Prior research has shown that rats with diet-induced obesity and obese humans both have high levels of leptin. Giving more to them is minimally effective. The researchers in this study, therefore, gave obese rats a mixture of the weight-loss drug sibutramine, known commercially as Meridia, and leptin, to see if the two substances together might help the overweight animals lose weight. The addition of leptin, they believed, would trick the brain into thinking that no weight was being lost.

"By preventing the decrease in leptin levels that normally occurs with weight loss, we theorized that sibutramine would be able to have a greater weight-loss effect," says Carol Boozer, D.Sc., assistant professor of nutritional medicine in the Institute of Human Nutrition at Columbia, and lead author of the study. Dr. Boozer is also director of the Energy Metabolism Laboratory in the New York Obesity Research Center at St. Luke's-Roosevelt Hospital Center.

"This study shows that an active system resists weight loss, but that the resistance can be overcome," says Dr. Louis J. Aronne, clinical associate professor of medicine at Weill Cornell Medical College and senior author on the study. "Hopefully, it will point us towards more successful treatments of obesity."

The investigators compared a group of obese rats getting the weight loss drug and leptin to three other weight-matched groups: one that received only saline; one that received sibutramine alone; and one that received only replacement levels of leptin.

They found that the rat group taking sibutramine alone lost more weight than rats that received either leptin or saline. The amount of weight lost on the drug, though, started to plateau after five days. But the rat group given a mixture of sibutramine and leptin shed significantly more weight than the group given sibutramine alone. Rats getting sibutramine and leptin also ate less food and had significantly less body fat.

Trials with the drug and leptin are under way to test whether the two together facilitate weight loss in obese people, too.

###

The William R. Berkley, Michael Steinhardt and Isaac Blech Research Fund, and the National Institute of Diabetes and Digestive and Kidney Diseases supported this research. Knoll Pharmaceuticals of Cedar Knolls, N.J., which manufactures Meridia, provided the researchers the drug at no cost for this study.

The research results are published in the August issue of the peer-reviewed medical journal Metabolism. Other researchers in this study were Dr. Rudolph L. Leibel, professor of pediatrics and medicine, P&S, head of the Division of Molecular Genetics at P&S, deputy director of the New York Obesity Research Center and co-director of the Naomi Berrie Diabetes Center; Robert J. Love, who was a graduate student at the Institute of Human Nutrition during the study; and Ming C. Cha, who was a postdoctoral fellow at the Institute and the Obesity Research Center during the study.

P&S is home to two of the researchers who participated in the experiments that first identified the leptin gene: Dr. Leibel and Yiying Zhang, Ph.D., assistant professor of molecular and cell biology in the Department of Pediatrics, division of molecular genetics. Dr. Zhang now studies the control of leptin gene expression in fat cells.

Obesity is a serious health threat in the United States. Since 1991, obesity among adults has increased by nearly 60 percent nationally, according to the Centers for Disease Control and Prevention.

Obesity is defined as having a body mass index of 30 or higher (this is equivalent to weight of 174 lbs. in a 5'5" woman, or 202 lbs. in a 5'10" male). Such people are often about 30 pounds or more overweight. Excess weight and physical inactivity account for more than 300,000 premature deaths each year, second only to tobacco-related deaths.

Being overweight makes it more likely that someone will develop health problems, such as heart disease, stroke, diabetes, certain types of cancer, gout, and gallbladder disease.


Story Source:

The above story is based on materials provided by Columbia University College Of Physicians And Surgeons. Note: Materials may be edited for content and length.


Cite This Page:

Columbia University College Of Physicians And Surgeons. "Leptin May Hold Key To Better Weight Loss." ScienceDaily. ScienceDaily, 1 October 2001. <www.sciencedaily.com/releases/2001/10/011001072714.htm>.
Columbia University College Of Physicians And Surgeons. (2001, October 1). Leptin May Hold Key To Better Weight Loss. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2001/10/011001072714.htm
Columbia University College Of Physicians And Surgeons. "Leptin May Hold Key To Better Weight Loss." ScienceDaily. www.sciencedaily.com/releases/2001/10/011001072714.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins